This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Ventas' Q3 FFO Meet Estimates on Higher Same-Store NOI, View Raised
by Zacks Equity Research
VTR's Q3 results reflect a year-over-year rise in revenues. The total property same-store NOI improves on strong performance across the business segments.
Medical Properties Stock Down 3% in 3 Months: Time to Buy or Red Flag?
by Rohit Vasant Fatarpekar
Despite strong healthcare industry fundamentals, investors seem pessimistic about MPW due to stock sale news, dividend pay cut and southward revision of FFO estimates.
Welltower's Q3 FFO Beats Estimates, Same-Store NOI Rises Y/Y
by Zacks Equity Research
WELL's Q3 results reflect higher same-store net operating income for the senior housing operating portfolio, driven by strong revenue per occupied room.
Healthpeak's Q3 FFO Beats Estimates, Same-Store NOI Rises
by Zacks Equity Research
DOC's Q3 FFO tops estimates. Results reflect a year-over-year rise in revenues and total merger-combined same-store cash (adjusted) NOI.
Healthpeak (DOC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Healthpeak (DOC) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Healthpeak (DOC) Beats Q3 FFO and Revenue Estimates
by Zacks Equity Research
Healthpeak (DOC) delivered FFO and revenue surprises of 2.27% and 1.66%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Highwoods Properties' Q3 FFO Beats Estimates, '24 View Raised
by Zacks Equity Research
HIW's Q3 results reflect healthy leasing activity with rent growth amid rising demand for high-quality office buildings.
Alexandria Q3 AFFO Misses Estimates, Revenues Increase Y/Y
by Zacks Equity Research
ARE's Q3 results reflect a year-over-year rise in revenues, backed by decent leasing activity and higher rental rates.
What's in the Cards for Healthpeak Properties This Earnings Season?
by Zacks Equity Research
DOC's Q3 earnings are likely to have benefited from rising healthcare spending and the aging population. However, higher interest expenses may have hurt it.
Curious about Healthpeak (DOC) Q3 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Healthpeak (DOC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.
Healthpeak Properties Stock Up 16.5% in 6 Months: Will It Rise Further?
by Zacks Equity Research
DOC to gain from robust demand for lab assets and an expected rise in senior citizens' healthcare spending, accretive investments and a solid balance sheet.
MPW Stock Surges 33.9% in a Month: Should You Buy Now or Wait?
by Zacks Equity Research
Medical Properties rides on interest rate cut, control over its real estate from Steward and balance-sheet strengthening efforts despite operator concentration.
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Ventas Secures Agreements With Kindred & ScionHealth for 23 LTACs
by Zacks Equity Research
To improve patient care facilities, VTR announces reaching an agreement with Kindred and ScionHealth regarding 23 long-term acute care hospitals.
Is it a Wise Decision to Hold Healthpeak Properties Stock Now?
by Zacks Equity Research
DOC is well-poised to gain from high demand for lab assets and rising senior citizens' healthcare spending despite competitive and high interest rate environment.
Gladstone Commercial Grows Industrial Property Base With Acquisition
by Zacks Equity Research
As part of its efforts to expand in strong industrial locations, GOOD acquires an industrial manufacturing, distribution and service facility in Midland, TX.
Is it Wise to Retain SL Green Stock in Your Portfolio Now?
by Zacks Equity Research
SLG is likely to benefit from healthy demand for premier office properties and a solid tenant base despite an elevated supply of office spaces and high interest rates.
Healthpeak Properties' Stock Rises 31% in 6 Months: Here's How
by Zacks Equity Research
High demand for lab assets and rising senior citizens' healthcare spending are likely to support DOC's performance.
Zacks Industry Outlook Healthpeak Properties, Lamar Advertising and Cousins Properties
by Zacks Equity Research
Healthpeak Properties, Lamar Advertising and Cousins Properties have been highlighted in this Industry Outlook article.
3 Equity REIT Stocks Worth Investing in as the Industry Rebounds
by Moumita C. Chattopadhyay
The Zacks REIT and Equity Trust - Other industry players such as DOC, LAMR and CUZ are likely to benefit from healthy fundamentals and improving demand.
Reasons to Add Healthpeak Properties (DOC) to Your Portfolio Now
by Zacks Equity Research
High demand for lab assets and rising senior citizens' healthcare spending benefit Healthpeak Properties (DOC).
BXP Rallies 19.5% in 3 Months: Will It Continue to Rise?
by Zacks Equity Research
BXP's assets in a few select markets, diversified tenant base, strategic expansions and a solid balance sheet position bode well for future growth.
Iron Mountain (IRM) Uses MongoDB for its New InSight DXP
by Zacks Equity Research
To manage physical and digital information, Iron Mountain (IRM) uses MongoDB Atlas as the data platform for its InSight DXP.
Healthpeak (DOC) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Healthpeak (DOC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
What's in the Cards for Medical Properties (MPW) in Q2 Earnings?
by Zacks Equity Research
While Medical Properties' (MPW) Q2 earnings are likely to have benefited from the favorable healthcare industry trends, high interest rates and exposure to certain troubled operators may have hurt it.